Anna-Lena Spetz

Company: TIRmed Pharma

Job title: Chief Scientific Officer & Founder

Seminars:

Immunoregulatory Oligonucleotide for the Treatment of Mild- Moderate Atopic Dermatitis. 11:15 am

Developing a non-steroid topical treatment in a small biotech:-possibilities and challenges Inducing immunoregulatory type immune responses in the skin to enhance preclinical modelling Reducing certain itch responses by an immunoregulatory oligonucleotideRead more

day: Day One